id: P31040
gene_symbol: SDHA
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  SDHA encodes the flavoprotein (Fp) subunit of succinate dehydrogenase (SDH, Complex II),
  a heterotetrameric enzyme (SDHA/SDHB/SDHC/SDHD) embedded in the mitochondrial inner membrane.
  SDHA contains a covalently bound FAD cofactor (attached at His99) and catalyzes the oxidation
  of succinate to fumarate as part of the TCA cycle. The electrons from succinate oxidation are
  transferred via FAD to the iron-sulfur clusters in SDHB and ultimately to ubiquinone bound
  at the SDHC/SDHD membrane interface, coupling the TCA cycle to the electron transport chain.
  Complex II is unique among OXPHOS complexes in that it does NOT pump protons across the inner
  membrane. SDHA also functions as a tumor suppressor; loss-of-function mutations cause
  paraganglioma/pheochromocytoma (PPGL5) via succinate accumulation and pseudohypoxic HIF1a
  stabilization. Biallelic mutations cause Leigh syndrome, mitochondrial complex II deficiency,
  and dilated cardiomyopathy.
alternative_products:
- name: '1'
  id: P31040-1
- name: '2'
  id: P31040-2
  sequence_note: VSP_055077
- name: '3'
  id: P31040-3
  sequence_note: VSP_055078
existing_annotations:
# ============================================================
# IBA ANNOTATIONS (phylogenetic inference from GO_Central)
# ============================================================
- term:
    id: GO:0008177
    label: succinate dehydrogenase (quinone) activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for the overall SDH quinone reductase activity. GO:0008177 is defined as
      "the overall reaction of the entire SDH complex" (succinate + quinone -> fumarate + quinol).
      The IBA uses the qualifier 'enables' which is debatable for a single subunit of a complex enzyme.
      However, SDHA alone can catalyze the succinate -> fumarate half-reaction (the succinate
      dehydrogenase activity per se), and it is the catalytic subunit where the substrate binding
      and FAD-mediated oxidation occurs. The full quinone reduction requires all four subunits.
      The IMP annotation from PMID:7550341 uses 'contributes_to' which is arguably more precise
      for the full quinone-dependent reaction. Nevertheless, IBA annotations are well-curated
      phylogenetic inferences and the 'enables' qualifier is defensible since SDHA provides the
      primary catalytic function of the complex. The deep research review (SDHA-deep-research-falcon.md)
      confirms that the FAD cofactor is covalently linked in the SDHA subunit via a conserved histidine,
      essential for catalysis in characterized complex II enzymes.
    action: ACCEPT
    reason: >-
      SDHA is the catalytic subunit of SDH complex containing the FAD cofactor and active site
      for succinate oxidation. While the full quinone reduction requires the entire complex,
      SDHA's role is central and catalytic. The IBA is phylogenetically sound. Both 'enables'
      and 'contributes_to' are defensible for GO:0008177 given SDHA is the primary catalytic
      subunit. Accept as-is.
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          The active site for succinate-fumarate interconversion is located at the interface
          between the FAD-binding domain and the capping domain
      - reference_id: PMID:7550341
        supporting_text: >-
          We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene
          of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency

- term:
    id: GO:0045273
    label: respiratory chain complex II (succinate dehydrogenase)
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation that SDHA is part of respiratory chain complex II. This is a core structural
      annotation for SDHA as the flavoprotein subunit of the SDH/Complex II heterotetramer
      (SDHA+SDHB+SDHC+SDHD). Confirmed by cryo-EM structure (PMID:37098072).
    action: ACCEPT
    reason: >-
      SDHA is unambiguously a subunit of Complex II. The cryo-EM structure at 2.86A shows all
      four subunits including SDHA in the complex (PMID:37098072). This is a core annotation.
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          All the four subunits (SDHA, SDHB, SDHC, and SDHD) were detected by SDS-PAGE
          (SI Appendix, Fig. S1D) and mass spectrometry (MS) (SI Appendix, Table S1).

- term:
    id: GO:0050660
    label: flavin adenine dinucleotide binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for FAD binding. SDHA contains a covalently bound FAD cofactor attached at
      His99 (Tele-8alpha-FAD histidine). This is confirmed by crystal and cryo-EM structures
      (PMID:32887801, PMID:37098072). Note that GO:0071949 (FAD binding) is also annotated
      via Reactome. GO:0050660 is the more general term. Both are appropriate; this IBA is correct.
    action: ACCEPT
    reason: >-
      FAD binding is a core molecular function of SDHA. The FAD cofactor is covalently attached
      to His99 and is essential for catalysis. Supported by multiple structural studies.
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          The hydrophilic head of human CII consists of the flavin adenine dinucleotide
          (FAD)-binding protein (SDHA)
      - reference_id: PMID:19628817
        supporting_text: >-
          Sdh5 is required for SDH-dependent respiration and for Sdh1 flavination (incorporation
          of the flavin adenine dinucleotide cofactor)

- term:
    id: GO:0006121
    label: mitochondrial electron transport, succinate to ubiquinone
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for the specific biological process of electron transport from succinate to
      ubiquinone. This is the defining biological process for Complex II/SDH in the mitochondrial
      electron transport chain. SDHA initiates this process by oxidizing succinate via FAD and
      passing electrons through the iron-sulfur centers of SDHB to ubiquinone at SDHC/SDHD.
    action: ACCEPT
    reason: >-
      This is a core biological process annotation for SDHA. The electron flow from succinate
      to ubiquinone begins at SDHA's FAD cofactor. This is the defining ETC function of Complex II.
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          we propose that the human CII succinate- and ubiquinone-binding sites are likely to be
          connected by a similar chain of redox centers that include FAD, [2Fe-2S], [4Fe-4S],
          [3Fe-4S], and heme b

- term:
    id: GO:0009055
    label: electron transfer activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for electron transfer activity. SDHA is the initial electron acceptor in
      Complex II, receiving electrons from succinate via its FAD cofactor. The electrons then
      transfer through the [2Fe-2S] cluster of SDHB. This is a core molecular function annotation.
    action: ACCEPT
    reason: >-
      SDHA performs electron transfer as part of the succinate-to-ubiquinone chain. The FAD cofactor
      accepts electrons from succinate and transfers them to the iron-sulfur protein SDHB.
      This is phylogenetically and biochemically well-supported.
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          Five prosthetic groups, FAD, [2Fe-2S], [4Fe-4S], [3Fe-4S], and a heme b are required
          for electron transfer flow from succinate to ubiquinone

# ============================================================
# IEA ANNOTATIONS (electronic/computational)
# ============================================================
- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      IEA annotation based on UniProt subcellular location mapping. SDHA is a peripheral membrane
      protein on the matrix side of the inner mitochondrial membrane, as part of Complex II.
      Confirmed by cryo-EM (PMID:37098072) and UniProt subcellular location annotation.
    action: ACCEPT
    reason: >-
      Correct localization. SDHA is the matrix-facing subunit of Complex II which is anchored
      in the inner mitochondrial membrane via SDHC and SDHD. The IEA mapping is accurate and
      consistent with experimental data including the cryo-EM structure.
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          The entire hydrophobic domain contains two membrane-anchored subunits: SDHC and SDHD

- term:
    id: GO:0006099
    label: tricarboxylic acid cycle
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for TCA cycle involvement. SDHA catalyzes step 6 of the TCA cycle: the
      oxidation of succinate to fumarate. This is one of the two core biological processes
      of Complex II (the other being ETC).
    action: ACCEPT
    reason: >-
      TCA cycle involvement is a core function of SDHA. The succinate to fumarate reaction
      is a canonical step of the TCA cycle. Widely supported by literature.
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          Human complex II is a key protein complex that links two essential energy-producing
          processes: the tricarboxylic acid cycle and oxidative phosphorylation

- term:
    id: GO:0008177
    label: succinate dehydrogenase (quinone) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for the same SDH quinone activity as the IBA above, inferred from
      combined automated methods (UniProt keyword, InterPro, EC number). Redundant with the
      IBA and IMP annotations but consistent.
    action: ACCEPT
    reason: >-
      Consistent with IBA and IMP annotations. Duplicates are expected when multiple evidence
      sources converge on the same annotation.

- term:
    id: GO:0016491
    label: oxidoreductase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for general oxidoreductase activity. SDHA catalyzes the oxidation of
      succinate (EC 1.3.5.1), making it an oxidoreductase. This is a correct but very broad
      parent term. The more specific child terms (GO:0008177, GO:0016627) are also annotated.
    action: ACCEPT
    reason: >-
      Correct but general. It is acceptable for IEA annotations to be broader than experimental
      annotations. The more specific GO:0008177 is also present.

- term:
    id: GO:0016627
    label: oxidoreductase activity, acting on the CH-CH group of donors
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation from InterPro mapping. SDHA oxidizes succinate to fumarate, converting
      a CH-CH single bond to a C=C double bond. This is an accurate intermediate-level
      classification of the catalytic activity.
    action: ACCEPT
    reason: >-
      Correct classification. Succinate oxidation to fumarate involves removal of two hydrogens
      from the CH2-CH2 group to form the trans double bond of fumarate. This InterPro-based
      IEA is accurate.

- term:
    id: GO:0022900
    label: electron transport chain
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation for general electron transport chain involvement from InterPro. This is
      broader than GO:0006121 (mitochondrial electron transport, succinate to ubiquinone)
      which is the more specific IBA annotation. Both are correct.
    action: ACCEPT
    reason: >-
      Correct but more general than the IBA annotation GO:0006121. Complex II is part of the
      electron transport chain. Acceptable for IEA to use the broader term.

- term:
    id: GO:0050660
    label: flavin adenine dinucleotide binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation for FAD binding from InterPro. Redundant with the IBA annotation for
      the same term. Both are correct.
    action: ACCEPT
    reason: >-
      Correct and consistent with the IBA annotation. FAD is covalently bound to SDHA at His99.

# ============================================================
# IPI ANNOTATIONS (protein-protein interaction)
# ============================================================
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:17353931
  review:
    summary: >-
      IPI annotation from large-scale mass spectrometry protein-protein interaction study
      (Ewing et al. 2007). The WITH/FROM field indicates interaction with HLA-B (P01889).
      This is from a high-throughput screen and the biological significance of an SDHA-HLA-B
      interaction is unclear. Likely a non-specific or indirect detection.
    action: KEEP_AS_NON_CORE
    reason: >-
      High-throughput protein-protein interaction data. The SDHA-HLA-B interaction has no
      known biological relevance and is likely an artifact of overexpression-based mass
      spectrometry. Furthermore, 'protein binding' is uninformative as a GO term. Keep as
      non-core.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19628817
  review:
    summary: >-
      IPI annotation for interaction between SDHA and SDHAF2/SDH5 (Q9NX18). Hao et al. (2009)
      showed that SDH5/SDHAF2 is required for flavination of succinate dehydrogenase. The
      interaction between SDHA and SDHAF2 is essential for covalent FAD attachment.
      This is a biologically meaningful interaction confirmed by UniProt (INTERACTION section)
      and multiple studies.
    action: KEEP_AS_NON_CORE
    reason: >-
      The SDHA-SDHAF2 interaction is biologically meaningful (required for FAD cofactor
      insertion), but 'protein binding' is too vague. The interaction is better captured by
      the functional context (SDHAF2 is a complex II assembly factor). Keep as non-core since
      the underlying biology is valid even though the GO term is uninformative.
    supported_by:
      - reference_id: PMID:19628817
        supporting_text: >-
          Both yeast and human Sdh5 interact with the catalytic subunit of the succinate
          dehydrogenase (SDH) complex ... Sdh5 is required for SDH-dependent respiration
          and for Sdh1 flavination

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:19688755
  review:
    summary: >-
      IPI annotation for interaction with SDHB (P21912) from LC-MS/MS analysis of blue native
      PAGE-separated complexes. This confirms the well-established SDHA-SDHB interaction as
      part of Complex II assembly.
    action: KEEP_AS_NON_CORE
    reason: >-
      The SDHA-SDHB interaction is a core biochemical feature of Complex II, but this is already
      captured by the CC annotation GO:0045273 (part_of respiratory chain complex II). The
      'protein binding' annotation is uninformative. Keep as non-core.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:24606901
  review:
    summary: >-
      IPI annotation for interaction with SDHB (P21912) from a study on cochaperone binding
      to LYR motifs for iron-sulfur cluster delivery. This relates to Complex II assembly.
    action: KEEP_AS_NON_CORE
    reason: >-
      Another SDHA-SDHB interaction detected in the context of iron-sulfur cluster delivery.
      Biologically relevant to Complex II assembly but 'protein binding' is uninformative.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:26496610
  review:
    summary: >-
      IPI annotation for interaction with SDHAF2 (Q9NX18) from a quantitative interactome study
      (Hein et al. 2015). Confirms the SDHA-SDHAF2 assembly factor interaction.
    action: KEEP_AS_NON_CORE
    reason: >-
      Confirms the SDHA-SDHAF2 interaction in an independent quantitative study. Biologically
      relevant but 'protein binding' remains uninformative as a GO term.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:26618866
  review:
    summary: >-
      IPI annotation for interaction with CFTR (P13569) from a study on deltaF508-CFTR
      interactome remodelling. The biological significance of SDHA-CFTR interaction is
      questionable -- this is likely a non-specific detection in a large-scale study.
    action: KEEP_AS_NON_CORE
    reason: >-
      The SDHA-CFTR interaction is of unclear biological significance. CFTR is an ABC
      transporter involved in chloride conductance, and its interaction with a mitochondrial
      enzyme is likely indirect or an artifact. Keep as non-core.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:26749241
  review:
    summary: >-
      IPI annotation for interaction with SDHB (P21912) from a study on SDHAF1 mutations
      impairing Fe-S cluster transfer to SDHB. Relevant to Complex II assembly.
    action: KEEP_AS_NON_CORE
    reason: >-
      SDHA-SDHB interaction confirmed in the context of Fe-S cluster assembly. Biologically
      meaningful but 'protein binding' is uninformative. Already captured by CC annotation.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28330616
  review:
    summary: >-
      IPI annotation for interaction with PTPN3 (P26045) from systematic analysis of human
      protein phosphatase interactions. The biological relevance of an SDHA-PTPN3 interaction
      is unclear. PTPN3 is a tyrosine phosphatase. SDHA is known to be phosphorylated at
      Tyr-215 by SRC, so a phosphatase interaction could be biologically relevant but is
      not well characterized.
    action: KEEP_AS_NON_CORE
    reason: >-
      High-throughput phosphatase interaction study. While SDHA is phosphorylated at Y215,
      the specific relevance of PTPN3 interaction is not established.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  review:
    summary: >-
      IPI annotation for interaction with SDHB (P21912) from architecture of the human
      interactome study (Huttlin et al. 2017). Confirms SDHA-SDHB subunit interaction.
    action: KEEP_AS_NON_CORE
    reason: >-
      Another confirmation of the SDHA-SDHB interaction. Already well established and
      captured by the CC annotation for Complex II membership.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  review:
    summary: >-
      IPI annotation for interaction with SDHAF2 (Q9NX18) from the same architecture of
      the human interactome study (Huttlin et al. 2017). This is the second GOA entry for
      this PMID, detecting the SDHA-SDHAF2 assembly factor interaction.
    action: KEEP_AS_NON_CORE
    reason: >-
      Confirms the SDHA-SDHAF2 interaction. SDHAF2 is the assembly factor required for
      FAD insertion into SDHA. Biologically meaningful but 'protein binding' is uninformative.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29128334
  review:
    summary: >-
      IPI annotation for interaction with HLA-B (P01889) from mitochondrial protein interaction
      map linked to neurodegeneration. Same interactor as PMID:17353931. The biological
      significance of SDHA-HLA-B interaction remains unclear.
    action: KEEP_AS_NON_CORE
    reason: >-
      Second independent detection of SDHA-HLA-B interaction, but the biological relevance
      remains unclear. HLA-B is an MHC class I molecule, not expected to functionally interact
      with a mitochondrial matrix enzyme.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29924966
  review:
    summary: >-
      IPI annotation for interaction with CFTR (P13569) from a proteomic variant approach study.
      Second SDHA-CFTR interaction, of unclear biological significance.
    action: KEEP_AS_NON_CORE
    reason: >-
      SDHA-CFTR interaction detected by proteomics. Unclear biological significance.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:31324722
  review:
    summary: >-
      IPI annotation for interaction with CFTR (P13569) from study on calpain 1 and
      Phe508del-CFTR. Third SDHA-CFTR interaction detection. Multiple detections suggest
      a real physical interaction but its functional significance for SDHA is unclear.
    action: KEEP_AS_NON_CORE
    reason: >-
      Third detection of SDHA-CFTR interaction. While multiple detections suggest a real
      interaction, the functional significance for SDHA function is unclear.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: >-
      IPI annotation for interaction with SDHB (P21912) from dual proteome-scale network
      study (Huttlin et al. 2021). Confirms the known Complex II SDHA-SDHB subunit interaction.
    action: KEEP_AS_NON_CORE
    reason: >-
      Confirms the SDHA-SDHB interaction. Well established and captured by CC annotation.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: >-
      IPI annotation for interaction with SDHAF2 (Q9NX18) from dual proteome-scale network
      study (Huttlin et al. 2021). This is the second GOA entry for this PMID, confirming
      the SDHA-SDHAF2 assembly factor interaction.
    action: KEEP_AS_NON_CORE
    reason: >-
      Confirms the SDHA-SDHAF2 interaction. Well established.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:35156780
  review:
    summary: >-
      IPI annotation for interaction with CFTR (P13569) from membrane two-hybrid screening.
      Fourth SDHA-CFTR interaction detection.
    action: KEEP_AS_NON_CORE
    reason: >-
      Yet another SDHA-CFTR detection. While robust, CFTR interaction is not relevant to
      the core function of SDHA.

# ============================================================
# LOCALIZATION ANNOTATIONS
# ============================================================
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation for mitochondrial localization via Ensembl Compara ortholog transfer.
      SDHA has a mitochondrial transit peptide (residues 1-42) and is localized to the
      mitochondrial matrix as part of Complex II.
    action: ACCEPT
    reason: >-
      Correct localization, well supported by multiple lines of evidence including
      the transit peptide and IDA evidence.

- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation for mitochondrial matrix localization via Ensembl Compara ortholog transfer.
      SDHA faces the matrix side of the inner membrane as a peripheral membrane protein.
    action: ACCEPT
    reason: >-
      Correct. SDHA is on the matrix side of the inner mitochondrial membrane, confirmed
      by cryo-EM structure (PMID:37098072) showing SDHA in the hydrophilic head of Complex II
      facing the matrix.
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          The hydrophilic head of human CII consists of the flavin adenine dinucleotide
          (FAD)-binding protein (SDHA) and the iron-sulfur protein (SDHB)

- term:
    id: GO:0045273
    label: respiratory chain complex II (succinate dehydrogenase)
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IEA annotation for Complex II membership via Ensembl Compara ortholog transfer.
      Redundant with IBA and other annotations for the same term.
    action: ACCEPT
    reason: >-
      Correct and consistent with IBA, ISS, IDA, and TAS annotations for this term.

- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: >-
      IDA annotation for mitochondrial localization from HPA immunofluorescence data.
      Direct experimental evidence of SDHA mitochondrial localization.
    action: ACCEPT
    reason: >-
      Direct experimental evidence of mitochondrial localization by immunofluorescence.

- term:
    id: GO:0006099
    label: tricarboxylic acid cycle
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-71403
  review:
    summary: >-
      TAS annotation from Reactome TCA cycle pathway. SDHA participates in the TCA cycle
      by catalyzing the succinate to fumarate step.
    action: ACCEPT
    reason: >-
      Core function annotation. Consistent with IEA and NAS annotations for the same term.
      SDHA is a canonical TCA cycle enzyme.

- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: NAS
  original_reference_id: PMID:30030361
  review:
    summary: >-
      NAS annotation from ComplexPortal based on review by Signes and Fernandez-Vizarra (2018)
      on assembly of OXPHOS complexes. SDHA is part of Complex II which is embedded in the
      inner mitochondrial membrane.
    action: ACCEPT
    reason: >-
      Correct localization. Complex II spans the inner membrane via SDHC/SDHD subunits, with
      SDHA on the matrix side as a peripheral membrane protein.

- term:
    id: GO:0006099
    label: tricarboxylic acid cycle
  evidence_type: NAS
  original_reference_id: PMID:30030361
  review:
    summary: >-
      NAS annotation from ComplexPortal for TCA cycle involvement. Redundant with other
      TCA cycle annotations but consistent.
    action: ACCEPT
    reason: >-
      Correct and consistent with other TCA cycle annotations from Reactome and IEA sources.

- term:
    id: GO:0006121
    label: mitochondrial electron transport, succinate to ubiquinone
  evidence_type: NAS
  original_reference_id: PMID:30030361
  review:
    summary: >-
      NAS annotation from ComplexPortal for the specific ETC process. Consistent with the
      IBA annotation for the same term.
    action: ACCEPT
    reason: >-
      Correct. This is a core biological process for SDHA/Complex II.

- term:
    id: GO:0042776
    label: proton motive force-driven mitochondrial ATP synthesis
  evidence_type: NAS
  original_reference_id: PMID:30030361
  review:
    summary: >-
      NAS annotation from ComplexPortal suggesting SDHA is involved in proton motive
      force-driven mitochondrial ATP synthesis. This annotation is problematic because
      Complex II does NOT pump protons across the inner mitochondrial membrane. Unlike
      Complexes I, III, and IV which translocate protons to generate the proton motive force,
      Complex II transfers electrons from succinate to ubiquinone without any proton pumping.
      Complex II contributes to ATP synthesis only indirectly by feeding reduced ubiquinol
      into the Q pool, which is then oxidized by Complex III (which does pump protons).
      Annotating SDHA with this term conflates electron donation to the Q pool with proton
      translocation.
    action: REMOVE
    reason: >-
      Complex II is the only OXPHOS complex that does NOT pump protons. The proton motive
      force is generated by Complexes I, III, and IV. Complex II feeds electrons into the
      ubiquinone pool but does not directly contribute to the proton gradient. This annotation
      is misleading and should be removed. The correct process annotation for SDHA is
      GO:0006121 (mitochondrial electron transport, succinate to ubiquinone).
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          The respiratory chain (also called electron transport chain) consists of complexes I-IV.
          It oxidizes the reducing equivalents in nicotinamide adenine dinucleotide (NADH) and
          succinate using molecular oxygen and couples the translocation of protons from the
          mitochondrial matrix into the intermembrane space
        # [Note: This passage describes the overall respiratory chain but the proton translocation
        # is performed by CI, CIII, CIV -- not CII. CII transfers electrons but does not pump protons.]

- term:
    id: GO:0071949
    label: FAD binding
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9854672
  review:
    summary: >-
      TAS annotation from Reactome for FAD binding. The Reactome entry R-HSA-9854672
      describes the covalent attachment of FAD to SDHA. GO:0071949 (FAD binding) specifically
      refers to binding the oxidized form of FAD, which is appropriate for SDHA.
    action: ACCEPT
    reason: >-
      Correct. SDHA covalently binds FAD at His99. This is the more specific FAD binding term
      compared to GO:0050660, and both are appropriate. Reactome accurately captures this step
      of Complex II maturation.

- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  review:
    summary: >-
      HTP annotation for mitochondrial localization from a quantitative high-confidence human
      mitochondrial proteome study (Morgenstern et al. 2021). SDHA was identified in the
      mitochondrial proteome.
    action: ACCEPT
    reason: >-
      Correct. SDHA is a well-established mitochondrial protein confirmed by proteomics.

- term:
    id: GO:0045273
    label: respiratory chain complex II (succinate dehydrogenase)
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation for Complex II membership by manual transfer from bovine ortholog
      (Q0QF01). Consistent with all other annotations for this term.
    action: ACCEPT
    reason: >-
      Correct. Transfer from the well-characterized bovine SDH complex.

# ============================================================
# KEY EXPERIMENTAL ANNOTATIONS
# ============================================================
- term:
    id: GO:0008177
    label: succinate dehydrogenase (quinone) activity
  evidence_type: IMP
  original_reference_id: PMID:7550341
  qualifier: contributes_to
  review:
    summary: >-
      IMP annotation with 'contributes_to' qualifier from the landmark Bourgeron et al. (1995)
      study. This study identified the first nuclear gene mutation causing mitochondrial
      respiratory chain deficiency -- an Arg554Trp mutation in SDHA causing Leigh syndrome
      with complex II deficiency. The 'contributes_to' qualifier is appropriate for GO:0008177
      since the GO term definition states "This term represents the overall reaction of the
      entire SDH complex." The full quinone reduction reaction requires all four subunits
      (SDHA provides succinate oxidation/FAD reduction, SDHB provides Fe-S electron relay,
      and SDHC/SDHD provide the quinone binding site). SDHA alone cannot complete the quinone
      reduction half of the reaction.
    action: ACCEPT
    reason: >-
      The 'contributes_to' qualifier is arguably more precise than 'enables' for GO:0008177
      since the GO definition explicitly states it represents the overall reaction of the
      entire complex. SDHA provides the succinate dehydrogenase half-reaction (via FAD) but
      quinone reduction requires the membrane-anchored subunits. Both qualifiers are defensible
      but 'contributes_to' is more conservative and accurate for this complex-level activity.
    supported_by:
      - reference_id: PMID:7550341
        supporting_text: >-
          We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene of the
          succinate dehydrogenase (SDH) in two siblings with complex II deficiency presenting
          as Leigh syndrome

- term:
    id: GO:0045273
    label: respiratory chain complex II (succinate dehydrogenase)
  evidence_type: IDA
  original_reference_id: PMID:37098072
  review:
    summary: >-
      IDA annotation for Complex II membership from the cryo-EM structure study (Du et al. 2023).
      This study resolved the human Complex II structure at 2.86A showing all four subunits.
      SDHA was directly identified in the complex by cryo-EM, SDS-PAGE, and mass spectrometry.
    action: ACCEPT
    reason: >-
      Direct experimental evidence from cryo-EM structure of human Complex II showing SDHA
      as a subunit.
    supported_by:
      - reference_id: PMID:37098072
        supporting_text: >-
          We observed all four subunits in a monomeric assembly (Fig. 1A). This arrangement
          is similar to that in W. succinogenes QFR

- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-70994
  review:
    summary: >-
      TAS annotation from Reactome for mitochondrial matrix localization. The Reactome entry
      describes the SDH complex dehydrogenation of succinate, placing SDHA in the matrix.
    action: ACCEPT
    reason: >-
      Correct. SDHA is on the matrix face of Complex II.

- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9854672
  review:
    summary: >-
      TAS from Reactome for matrix localization, associated with the FAD attachment to SDHA
      reaction which occurs in the matrix.
    action: ACCEPT
    reason: >-
      Correct. FAD attachment to SDHA occurs in the mitochondrial matrix.

- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9854961
  review:
    summary: >-
      TAS from Reactome for matrix localization, associated with SDHAF4 binding to FAD-SDHA.
    action: ACCEPT
    reason: >-
      Correct. SDHAF4 binding to FAD-SDHA occurs in the mitochondrial matrix during Complex II
      assembly.

- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9855212
  review:
    summary: >-
      TAS from Reactome for matrix localization, associated with SDHA binding to SDHB.
    action: ACCEPT
    reason: >-
      Correct. SDHA-SDHB subcomplex formation occurs in the matrix.

- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9855252
  review:
    summary: >-
      TAS from Reactome for matrix localization, associated with SDHA:SDHB binding to SDHC:SDHD.
    action: ACCEPT
    reason: >-
      Correct. The final assembly step of Complex II involves SDHA:SDHB joining SDHC:SDHD
      at the membrane.

- term:
    id: GO:0008177
    label: succinate dehydrogenase (quinone) activity
  evidence_type: IMP
  original_reference_id: PMID:24781757
  review:
    summary: >-
      IMP annotation from Renkema et al. (2015) who characterized SDHA mutations causing
      multisystem mitochondrial disease. They showed that the c.565T>G mutation severely
      affects enzyme activity and confirmed pathogenicity by lentiviral complementation.
      This annotation uses 'enables' qualifier (no explicit 'contributes_to' in GOA TSV line).
    action: ACCEPT
    reason: >-
      Valid IMP evidence showing that SDHA mutations directly impair SDH enzyme activity.
      The study demonstrates that specific SDHA mutations cause isolated complex II deficiency
      through impaired catalysis.
    supported_by:
      - reference_id: PMID:24781757
        supporting_text: >-
          For the third new mutation, c.565T>G, we show that it severely affects enzyme activity.
          Its pathogenicity was confirmed by lentiviral complementation experiments on the
          fibroblasts of patients carrying this mutation

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:23747254
  review:
    summary: >-
      IPI annotation for interaction with TRAP1 (Q12931) from Sciacovelli et al. (2013).
      This study showed that the mitochondrial chaperone TRAP1 binds to and inhibits SDH
      complex (specifically SDHA), leading to succinate accumulation and pseudohypoxic
      HIF1a stabilization in tumors. This is a functionally significant interaction demonstrated
      by co-immunoprecipitation, BN-PAGE, and crosslinking experiments.
    action: KEEP_AS_NON_CORE
    reason: >-
      The SDHA-TRAP1 interaction is biologically significant (TRAP1 inhibits SDH activity
      to promote the Warburg effect in tumors), but 'protein binding' remains uninformative.
      The interaction is regulatory rather than a core molecular function of SDHA.
    supported_by:
      - reference_id: PMID:23747254
        supporting_text: >-
          TRAP1 binds to and inhibits succinate dehydrogenase (SDH), the complex II of the
          respiratory chain. The respiratory downregulation elicited by TRAP1 interaction
          with SDH promotes tumorigenesis by priming the succinate-dependent stabilization
          of the proneoplastic transcription factor HIF1a

- term:
    id: GO:0005743
    label: mitochondrial inner membrane
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation for inner membrane localization by transfer from bovine ortholog (Q0QF01).
      Consistent with other annotations and cryo-EM evidence.
    action: ACCEPT
    reason: >-
      Correct. Transfer from well-characterized bovine SDH complex.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15961414
  review:
    summary: >-
      IPI annotation for interaction with frataxin (Q16595) from Gonzalez-Cabo et al. (2005).
      This study showed physical interaction between human frataxin and human succinate
      dehydrogenase complex subunits, suggesting a role for frataxin in the mitochondrial
      electron transport chain. Frataxin is involved in iron-sulfur cluster biogenesis.
    action: KEEP_AS_NON_CORE
    reason: >-
      The SDHA-frataxin interaction is biologically interesting given frataxin's role in
      Fe-S cluster biogenesis and Friedreich ataxia pathogenesis. However, 'protein binding'
      is uninformative and this represents a regulatory/assembly interaction rather than a
      core SDHA function.
    supported_by:
      - reference_id: PMID:15961414
        supporting_text: >-
          We also demonstrate a physical interaction between human frataxin and human succinate
          dehydrogenase complex subunits, suggesting also a key role of frataxin in the
          mitochondrial electron transport chain in humans

- term:
    id: GO:0006105
    label: succinate metabolic process
  evidence_type: IDA
  original_reference_id: PMID:7550341
  review:
    summary: >-
      IDA annotation for succinate metabolic process from Bourgeron et al. (1995). SDHA
      catalyzes the oxidation of succinate to fumarate, which is central to succinate
      metabolism. This is correct but less specific than the TCA cycle annotation.
    action: ACCEPT
    reason: >-
      Correct. SDHA directly metabolizes succinate as part of its catalytic function.
      This is a reasonable biological process annotation complementing the TCA cycle
      and ETC annotations.

- term:
    id: GO:0007399
    label: nervous system development
  evidence_type: IMP
  original_reference_id: PMID:16361598
  review:
    summary: >-
      IMP annotation for nervous system development from Horvath et al. (2006). This study
      described a child with Leigh syndrome caused by compound heterozygous SDHA mutations
      (W119X and A83V), presenting with severe progressive neurodegenerative disorder causing
      epilepsy, psychomotor retardation, and tetraspasticity starting at age five months.
      The IMP logic is that SDHA mutations cause a neurodevelopmental phenotype, therefore
      SDHA is involved in nervous system development. However, this is a classic case of
      over-annotation. SDHA is a housekeeping metabolic enzyme. The nervous system is particularly
      sensitive to mitochondrial dysfunction due to its high energy demands, but SDHA is not
      specifically involved in nervous system development. The neurological phenotype is a
      secondary consequence of impaired cellular energy production, not a direct developmental
      role for SDHA in neural patterning or differentiation.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is a clear over-annotation. SDHA mutations cause Leigh syndrome with neurological
      features because the nervous system is especially vulnerable to mitochondrial energy
      deficits, not because SDHA has a specific role in neural development. The nervous system
      phenotype is a secondary consequence of impaired oxidative phosphorylation. By this logic,
      any essential metabolic gene causing disease with neurological symptoms would be annotated
      with 'nervous system development', which is not informative.
    supported_by:
      - reference_id: PMID:16361598
        supporting_text: >-
          The clinical symptoms started at age five months and led to a severe progressive
          neurodegenerative disorder causing epilepsy, psychomotor retardation, and
          tetraspasticity. Biochemical measurement of skeletal muscle showed a severe
          decrease in mitochondrial complex II

- term:
    id: GO:0022904
    label: respiratory electron transport chain
  evidence_type: IDA
  original_reference_id: PMID:7550341
  review:
    summary: >-
      IDA annotation for respiratory electron transport chain from Bourgeron et al. (1995).
      The study showed that SDHA mutation causes complex II deficiency, directly demonstrating
      SDHA's role in the respiratory electron transport chain. This is broader than GO:0006121
      but still accurate.
    action: ACCEPT
    reason: >-
      Correct. SDHA is part of Complex II which is a component of the respiratory electron
      transport chain. The Bourgeron et al. study directly demonstrated that SDHA mutation
      leads to respiratory chain deficiency.
    supported_by:
      - reference_id: PMID:7550341
        supporting_text: >-
          We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene
          of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency
          presenting as Leigh syndrome

- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: PMID:16826196
  review:
    summary: >-
      IDA annotation for mitochondrial localization from Huang et al. (2007). This study
      was about Complex I and IFN-beta/RA-induced cell death. The connection to SDHA
      mitochondrial localization is indirect -- the study mentions upregulation of MRC
      complex subunits but is primarily about Complex I (GRIM-19, NDUFS3). SDHA
      mitochondrial localization is well-established from other sources regardless.
    action: ACCEPT
    reason: >-
      Mitochondrial localization of SDHA is beyond question, even though this particular
      reference is not the strongest evidence for SDHA specifically.

- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: PMID:7550341
  review:
    summary: >-
      IDA annotation for mitochondrial localization from Bourgeron et al. (1995). The study
      demonstrated mitochondrial respiratory chain deficiency from SDHA mutation, placing
      SDHA in the mitochondrion.
    action: ACCEPT
    reason: >-
      Correct mitochondrial localization, supported by the original study showing that SDHA
      mutation causes mitochondrial respiratory chain deficiency.

- term:
    id: GO:0006099
    label: tricarboxylic acid cycle
  evidence_type: TAS
  original_reference_id: PMID:7550341
  review:
    summary: >-
      TAS annotation for TCA cycle from Bourgeron et al. (1995). The study refers to SDH
      as part of the TCA cycle/respiratory chain.
    action: ACCEPT
    reason: >-
      Correct. The succinate to fumarate reaction is a canonical TCA cycle step.

- term:
    id: GO:0045273
    label: respiratory chain complex II (succinate dehydrogenase)
  evidence_type: TAS
  original_reference_id: PMID:7550341
  review:
    summary: >-
      TAS annotation for Complex II membership from Bourgeron et al. (1995). The study
      directly discusses Complex II deficiency from SDHA mutation.
    action: ACCEPT
    reason: >-
      Correct. SDHA is the flavoprotein subunit of Complex II.

# ============================================================
# NEW ANNOTATIONS (missing from current set)
# ============================================================
- term:
    id: GO:0000104
    label: succinate dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:7550341
  review:
    summary: >-
      GO:0000104 (succinate dehydrogenase activity) is defined as "Catalysis of the reaction:
      succinate + acceptor = fumarate + reduced acceptor." This is a more appropriate molecular
      function term for SDHA than GO:0008177 (quinone-specific) when annotating the subunit
      alone, because SDHA catalyzes the succinate to fumarate reaction via its FAD cofactor
      regardless of the downstream electron acceptor. The Bourgeron et al. study demonstrated
      that mutation of SDHA impairs succinate dehydrogenase activity. This annotation should
      use the 'enables' qualifier since SDHA alone (with its FAD cofactor) is sufficient to
      catalyze succinate oxidation.
    action: NEW
    reason: >-
      GO:0000104 more precisely captures SDHA's intrinsic catalytic function (succinate
      oxidation with a generic acceptor) as opposed to GO:0008177 which specifies the
      quinone-dependent overall complex reaction. SDHA alone can oxidize succinate to
      fumarate; the FAD cofactor serves as the immediate electron acceptor. This term
      fills a gap where the current annotations only capture the complex-level activity.
    supported_by:
      - reference_id: PMID:7550341
        supporting_text: >-
          The deleterious effect of the Arg to Trp substitution on the catalytic activity
          of SDH was observed in a SDH- yeast strain transformed with mutant Fp cDNA

references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:15961414
  title: Frataxin interacts functionally with mitochondrial electron transport chain
    proteins.
  findings:
    - statement: >-
        Frataxin physically interacts with succinate dehydrogenase complex subunits SDHA
        and SDHB in both yeast and humans, suggesting a role for frataxin in the mitochondrial
        electron transport chain.
      supporting_text: >-
        We also demonstrate a physical interaction between human frataxin and human succinate
        dehydrogenase complex subunits, suggesting also a key role of frataxin in the
        mitochondrial electron transport chain in humans
- id: PMID:16361598
  title: Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate
    dehydrogenase (SDHA).
  findings:
    - statement: >-
        Compound heterozygous SDHA mutations (W119X nonsense in exon 4 and A83V missense in
        exon 3) cause Leigh syndrome with severe complex II deficiency demonstrated by
        biochemical measurement in skeletal muscle.
      supporting_text: >-
        Biochemical measurement of skeletal muscle showed a severe decrease in mitochondrial
        complex II. Sequencing of SDHA revealed compound heterozygosity for a nonsense
        mutation in exon 4 (W119X) and a missense mutation in exon 3 (A83V), both absent
        in normal controls.
      reference_section_type: ABSTRACT
      full_text_unavailable: true
    - statement: >-
        Genetic heterogeneity exists for isolated complex II deficiency; six additional
        patients with Leigh or Leigh-like syndrome and complex II deficiency did not harbor
        SDHA mutations.
      supporting_text: >-
        In six additional patients--five with Leigh or Leigh-like syndrome and one with
        neuropathy and ataxia associated with isolated deficiency of complex II--mutations
        in SDHA were not detected, indicating genetic heterogeneity.
      reference_section_type: ABSTRACT
      full_text_unavailable: true
- id: PMID:16826196
  title: 'Coupling mitochondrial respiratory chain to cell death: an essential role
    of mitochondrial complex I in the interferon-beta and retinoic acid-induced cancer
    cell death.'
  findings:
    - statement: >-
        IFN-beta/RA upregulates expression of mitochondrial respiratory chain complex subunits.
        Study is primarily about Complex I (GRIM-19, NDUFS3); SDHA relevance is indirect,
        as the study demonstrates that MRC upregulation drives ROS-mediated cancer cell death.
      supporting_text: >-
        We found that IFN-beta/RA upregulates the expression of MRC complex subunits.
        Mitochondrial-nuclear translocation of these subunits was not observed, but
        overproduction of reactive oxygen species (ROS), which causes loss of mitochondrial
        function, was detected upon IFN-beta/RA treatment.
      reference_section_type: ABSTRACT
      full_text_unavailable: true
- id: PMID:17353931
  title: Large-scale mapping of human protein-protein interactions by mass spectrometry.
  findings: []
- id: PMID:19628817
  title: SDH5, a gene required for flavination of succinate dehydrogenase, is mutated
    in paraganglioma.
  findings:
    - statement: >-
        SDH5/SDHAF2 physically interacts with the catalytic subunit of the SDH complex
        (Sdh1 in yeast, SDHA in humans) and is required for covalent flavination, i.e.
        incorporation of the FAD cofactor into the flavoprotein subunit.
      supporting_text: >-
        Both yeast and human Sdh5 interact with the catalytic subunit of the succinate
        dehydrogenase (SDH) complex, a component of both the electron transport chain and
        the tricarboxylic acid cycle. Sdh5 is required for SDH-dependent respiration and
        for Sdh1 flavination (incorporation of the flavin adenine dinucleotide cofactor).
      reference_section_type: ABSTRACT
      full_text_unavailable: true
    - statement: >-
        Germline loss-of-function mutations in human SDH5/SDHAF2 segregate with hereditary
        paraganglioma, linking SDHA flavination assembly to tumor suppression.
      supporting_text: >-
        Germline loss-of-function mutations in the human SDH5 gene, located on chromosome
        11q13.1, segregate with disease in a family with hereditary paraganglioma, a
        neuroendocrine tumor previously linked to mutations in genes encoding SDH subunits.
      reference_section_type: ABSTRACT
      full_text_unavailable: true
- id: PMID:19688755
  title: LC-MS/MS as an alternative for SDS-PAGE in blue native analysis of protein
    complexes.
  findings: []
- id: PMID:23747254
  title: The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting
    succinate dehydrogenase.
  findings:
    - statement: >-
        TRAP1 physically interacts with SDH complex II, confirmed by co-immunoprecipitation,
        BN-PAGE, and chemical crosslinking. Two distinct TRAP1/SDH complexes are formed
        in mitochondria.
      supporting_text: "We confirmed the interaction between TRAP1 and complex II/SDH through\
        \ further approaches, including (1) immunoprecipitation, finding coimmunoprecipitation\
        \ (coIP) of TRAP1 with SDH and vice versa (Figure 3C), and (2) mitochondrial protein\
        \ crosslinking with dimethyl 3,3\u2032-dithiobis-propionimidate (DTBP), a homobifunctional\
        \ compound that reacts with the primary amines of two interacting proteins at an average\
        \ distance of about 8\u00a0\u00c5 (Giorgio et al., 2009), followed by TRAP1 immunoprecipitation\
        \ in order to determine whether TRAP1 and SDH are closely associated. We found that\
        \ two TRAP1/SDH complexes are formed in mitochondria (Figure 3D)."
      reference_section_type: RESULTS
      full_text_unavailable: false
    - statement: >-
        TRAP1 knockdown increases SQR enzymatic activity without affecting complex II protein
        levels. TRAP1 re-expression restores inhibition, and the Hsp90 inhibitor 17-AAG
        reverses TRAP1-mediated SDH inhibition, demonstrating the inhibition is reversible.
      supporting_text: >-
        We found that SQR enzymatic activity was increased in mitochondria from shTRAP1
        cells relative to those derived from control cells (Figures 4A, S2A, and S2B).
        TRAP1 did not affect either the cytochrome oxidase enzymatic activity of complex IV
        (Figure S2C) or complex II protein levels (Figure S2D) or mitochondrial mass
        (Figure S2E).
      reference_section_type: RESULTS
      full_text_unavailable: false
    - statement: >-
        TRAP1-mediated SDH inhibition causes intracellular succinate accumulation and
        pseudohypoxic HIF1a stabilization (independent of oxygen deprivation),
        establishing a mechanism for the Warburg effect in tumors via SDH regulation.
      supporting_text: "We observe that TRAP1-mediated inhibition of SDH limits the maximal\
        \ rate of respiration and leads to succinate accumulation followed by HIF1\u03b1,\
        \ but not HIF2\u03b1, stabilization. Remarkably, the membrane-permeable succinate\
        \ analog dimethyl succinate could both elicit HIF1\u03b1 stabilization and rescue\
        \ the tumorigenic phenotype of shTRAP1 cells, highlighting the mechanistic connection\
        \ between TRAP1-dependent succinate accumulation and HIF1\u03b1-dependent tumor\
        \ formation."
      reference_section_type: DISCUSSION
      full_text_unavailable: false
    - statement: >-
        The SDH inhibitor 3-nitropropionic acid (3-NP) inactivates SDH by covalent binding
        with an Arg residue in the catalytic core of SDHA, confirming SDHA as the site of
        catalytic activity in Complex II.
      supporting_text: >-
        A low concentration of the ETC complex II inhibitors 3-nitropropionic acid (3-NP),
        which inactivates SDH after covalent binding with an Arg residue in the catalytic
        core of SDHA (Huang et al., 2006), or thenoyltrifluoroacetone (TTFA), which blocks
        electron transfer from succinate to coenzyme Q at the quinone-binding site in
        subunits B and D (Huang et al., 2006), inhibited OCR in shTRAP1 cells but were
        inactive in the presence of TRAP1 (Figures S4B and S4C), paralleling the
        downmodulation of the SQR activity induced by 3-NP only in TRAP1-expressing
        mitochondria (Figure 5E).
      reference_section_type: RESULTS
      full_text_unavailable: false
- id: PMID:24606901
  title: Cochaperone binding to LYR motifs confers specificity of iron sulfur cluster
    delivery.
  findings: []
- id: PMID:24781757
  title: 'SDHA mutations causing a multisystem mitochondrial disease: novel mutations
    and genetic overlap with hereditary tumors.'
  findings:
    - statement: >-
        Novel SDHA mutations causing isolated complex II deficiency with Leigh syndrome
        and leukodystrophy. Mutation c.565T>G severely affects enzyme activity, confirmed
        by lentiviral complementation. Genetic overlap between mitochondrial disease and
        hereditary tumor mutations in SDHA.
- id: PMID:26496610
  title: A human interactome in three quantitative dimensions organized by stoichiometries
    and abundances.
  findings: []
- id: PMID:26618866
  title: F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.
  findings: []
- id: PMID:26749241
  title: Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB.
  findings: []
- id: PMID:28330616
  title: Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.
  findings: []
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings: []
- id: PMID:29128334
  title: A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration
    Reveals New Mechanisms of Redox Homeostasis and NF-B Signaling.
  findings: []
- id: PMID:29924966
  title: A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited
    and Somatic Disease.
  findings: []
- id: PMID:30030361
  title: Assembly of mammalian oxidative phosphorylation complexes I-V and supercomplexes.
  findings:
    - statement: >-
        Review of OXPHOS complex assembly. Complex II (SDH) comprises SDHA, SDHB, SDHC, SDHD.
        Assembly involves FAD insertion into SDHA by SDHAF2, followed by SDHA-SDHB dimerization
        and insertion into the membrane via SDHC-SDHD.
- id: PMID:31324722
  title: Inhibition of calpain 1 restores plasma membrane stability to pharmacologically
    rescued Phe508del-CFTR variant.
  findings: []
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
- id: PMID:34800366
  title: Quantitative high-confidence human mitochondrial proteome and its dynamics
    in cellular context.
  findings: []
- id: PMID:35156780
  title: CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput
    screening system.
  findings: []
- id: PMID:37098072
  title: Structure of the human respiratory complex II.
  findings:
    - statement: >-
        Cryo-EM structure of human Complex II at 2.86A resolution showing all four subunits
        (SDHA, SDHB, SDHC, SDHD) with FAD, three Fe-S clusters, heme b, and ubiquinone.
        SDHA contains four subdomains: FAD-binding, capping, helical, and C-terminal domains.
        The active site for succinate-fumarate interconversion is at the interface of the
        FAD-binding and capping domains. Electron transfer pathway from FAD through Fe-S
        clusters to ubiquinone is proposed.
- id: PMID:7550341
  title: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial
    respiratory chain deficiency.
  findings:
    - statement: >-
        First identification of a nuclear gene mutation causing mitochondrial respiratory chain
        deficiency. Homozygous Arg554Trp mutation in SDHA causes Leigh syndrome with complex II
        deficiency in two siblings born to consanguineous parents.
      supporting_text: >-
        We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene of the
        succinate dehydrogenase (SDH) in two siblings with complex II deficiency presenting as
        Leigh syndrome. Both patients were homozygous for an Arg554Trp substitution in the Fp
        subunit. Their parents (first cousins) were heterozygous for the mutation that occurred
        in a conserved domain of the protein and was absent from 120 controls.
      reference_section_type: ABSTRACT
      full_text_unavailable: true
    - statement: >-
        The deleterious effect of the Arg554Trp mutation on SDH catalytic activity was
        demonstrated in a yeast complementation assay using an SDH-deficient strain
        transformed with mutant Fp cDNA.
      supporting_text: >-
        The deleterious effect of the Arg to Trp substitution on the catalytic activity of SDH
        was observed in a SDH- yeast strain transformed with mutant Fp cDNA.
      reference_section_type: ABSTRACT
      full_text_unavailable: true
    - statement: >-
        The Fp subunit gene is duplicated in the human genome at chromosomes 3q29 and 5p15,
        with only the chromosome 5 copy expressed.
      supporting_text: >-
        The Fp subunit gene is duplicated in the human genome (3q29; 5p15), with only the gene
        on chromosome 5 expressed in human-hamster somatic cell hybrids. This is the first
        report of a nuclear gene mutation causing a mitochondrial respiratory chain deficiency
        in humans.
      reference_section_type: ABSTRACT
      full_text_unavailable: true
- id: Reactome:R-HSA-70994
  title: SDH complex dehydrogenates succinate
  findings: []
- id: Reactome:R-HSA-71403
  title: Citric acid cycle (TCA cycle)
  findings: []
- id: Reactome:R-HSA-9854672
  title: FAD attaches to SDHA
  findings: []
- id: Reactome:R-HSA-9854961
  title: SDHAF4 binds to FAD-SDHA
  findings: []
- id: Reactome:R-HSA-9855212
  title: SDHA binds to SDHB
  findings: []
- id: Reactome:R-HSA-9855252
  title: SDHA:SDHB binds to SDHC:SDHD
  findings: []
- id: file:human/SDHA/SDHA-deep-research-falcon.md
  title: Deep research review of SDHA gene function (Falcon provider)
  findings:
    - statement: >-
        SDHA encodes the covalently flavinylated FAD-containing flavoprotein subunit of
        mitochondrial complex II. Its catalytic role in succinate oxidation and electron
        transfer to ubiquinone is conserved. SDHx genes including SDHA contribute to
        paraganglioma/pheochromocytoma (PPGL) genetics.
      supporting_text: >-
        Complex II (succinate dehydrogenase, SDH) catalyzes the oxidation of succinate
        to fumarate, coupling two-electron transfer via FAD and iron-sulfur centers to
        reduce ubiquinone to ubiquinol in the inner mitochondrial membrane
core_functions:
- molecular_function:
    id: GO:0009055
    label: electron transfer activity
  contributes_to_molecular_function:
    id: GO:0008177
    label: succinate dehydrogenase (quinone) activity
  directly_involved_in:
    - id: GO:0006121
      label: mitochondrial electron transport, succinate to ubiquinone
    - id: GO:0006099
      label: tricarboxylic acid cycle
  locations:
    - id: GO:0045273
      label: respiratory chain complex II (succinate dehydrogenase)
    - id: GO:0005759
      label: mitochondrial matrix
  description: >-
    SDHA is the catalytic flavoprotein subunit of succinate dehydrogenase (Complex II).
    It contains a covalently bound FAD cofactor at His99 and catalyzes the oxidation of
    succinate to fumarate as part of the TCA cycle (GO:0006099). The electrons are transferred
    via FAD through SDHB iron-sulfur centers to ubiquinone, coupling the TCA cycle to the
    electron transport chain (GO:0006121). SDHA enables electron transfer activity (GO:0009055)
    and contributes to the overall succinate dehydrogenase quinone activity (GO:0008177) of
    the Complex II heterotetramer. The complex resides in the inner mitochondrial membrane
    with SDHA facing the matrix.
  supported_by:
    - reference_id: PMID:37098072
      supporting_text: >-
        Human complex II is a key protein complex that links two essential energy-producing
        processes: the tricarboxylic acid cycle and oxidative phosphorylation
    - reference_id: PMID:7550341
      supporting_text: >-
        We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene
        of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency
